Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.72M | -3.71M | -2.10M | -2.06M | -2.66M |
| Total Depreciation and Amortization | 69.10K | 68.90K | 70.40K | 68.90K | 66.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 1.31M | -2.57M | -2.52M | 3.16M |
| Change in Net Operating Assets | -- | -- | 1.63M | 1.59M | -- |
| Cash from Operations | -2.34M | -2.33M | -2.98M | -2.92M | 566.60K |
| Capital Expenditure | -900.00 | -900.00 | -11.40K | -11.20K | -800.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -900.00 | -900.00 | -11.40K | -11.20K | -800.00 |
| Total Debt Issued | -- | -- | 1.50M | 1.50M | -- |
| Total Debt Repaid | -1.59M | -1.59M | -15.60K | -15.60K | -14.70K |
| Issuance of Common Stock | 165.80K | 165.80K | 0.00 | 0.00 | 6.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -264.90K |
| Cash from Financing | -936.00K | -933.00K | 950.90K | 931.20K | 3.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.27M | -3.26M | -2.04M | -2.00M | 4.37M |